Hikma Fails To Nix Vascepa Induced Infringement Case Early On
Hikma And Health Net Cases ‘Can Move To Discovery’
In a suit closely watched by industry, a US district magistrate judge found that Amarin had at least stated a plausible claim in its case accusing Hikma and US healthcare insurance provider Health Net of induced infringement of Vascepa method-of-use patents, which Hikma has carved out of its generic label.
